




<rss xmlns:a10="http://www.w3.org/2005/Atom" version="2.0">
    <channel>
        <title>Cardiac Surgery and Arrhythmias</title>
        <link>http://www.acc.org/Feed?clinicalTopicID=bec15588-b83f-48f6-b6e7-acf0671bae3e</link>
        <description>Clinical Topic Feed: Cardiac Surgery and Arrhythmias</description>
        <language>en</language>

        

                <item>
                    <title>Eagle&#226;€™s Eye View: Imaging Identifies HCM Patients at High-Risk of Adverse Outcomes </title>
<link>/Latest-in-Cardiology/Articles/2026/05/20/13/40/eagles-eye-view-20may2026</link>                    <description>In this week&#226;€™s View, Dr. Eagle reviews evidence supporting the use of cardiac magnetic resonance (CMR) and NT-proBNP in hypertrophic cardiomyopathy (HCM) risk assessment.</description>
                    <pubdate>1779288780000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC Journals Science at ESC Heart Failure Congress 2026</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/05/11/15/12/JACC-Journals-Science-at-ESC-Heart-Failure-Congress-2026</link>                    <description>Findings from several studies presented at ESC Heart Failure Congress 2026 in Barcelona, Spain, were simultaneously published in JACC and JACC: Heart Failure, covering topics like arrhythmic burden in cardiac amyloidosis (CA), stroke and bleeding risk in CA...</description>
                    <pubdate>1778607960000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>SURVIV: mViV vs. rMVR For Mitral Bioprosthetic Valve Dysfunction</title>
<link>/Latest-in-Cardiology/Articles/2026/03/25/21/27/sun-4pm-surviv-acc-2026</link>                    <description>Among patients with a failed mitral bioprosthetic valve, transcatheter mitral valve-in-valve (mVIV) treatment was associated with a lower rate of death or disabling stroke at one year compared with standard repeat mitral valve replacement surgery (rMVR), according to results from the SURVIV study presented during a Late-Breaking Clinical Trial session at ACC.26 in New Orleans.</description>
                    <pubdate>1774818000000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>New Concise Clinical Guidance Addresses Outpatient Management of Isolated Left-to-Right Shunt Lesions in Pediatric Patients</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/03/24/18/20/New-CCG-Isolated-Left-to-Right-Shunt-Lesions-in-Pediatric-Patients</link>                    <description>Outpatient management of isolated left-to-right shunt lesions in pediatric patients with congenital heart disease is the focus of a new 2026 ACC Concise Clinical Guidance report.</description>
                    <pubdate>1774533600000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>JACC State-of-the-Art Review Highlights Growing Need For dLVAD-Related Emergency Response Resources</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/03/12/18/40/JACC-State-of-the-Art</link>                    <description>With the population of stage D heart failure (HF) patients supported with durable left ventricular assist devices (dLVAD) rapidly expanding, a State-of-the-Art Review published in JACC provides a comprehensive overview of support and management of dLVAD-related emergencies, with an intent to provide a rapid-response guide for clinicians who encounter emergencies in patients with dLVADs.</description>
                    <pubdate>1773343260000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Can Moderate Wine Intake Reduce CV Risk?</title>
<link>/Latest-in-Cardiology/Articles/2026/03/04/14/11/eagles-eye-view-04mar2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle looks at increased one-year mortality in younger patients undergoing transcatheter aortic valve replacement (TAVR).</description>
                    <pubdate>1772636400000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>VERITAS: Amulet 360 LAAO Safe, Effective</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/02/17/14/32/VERITAS</link>                    <description>The Amulet 360, Abbott&#39;s next-generation dual-seal left atrial appendage occlusion (LAAO) device, is effective and safe at 45 days according to the results of the VERITAS study published Feb. 6 in JACC: Clinical Electrophysiology.</description>
                    <pubdate>1771432200000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Noninvasive Predictors of LA Compliance Post TMVT</title>
<link>/Latest-in-Cardiology/Journal-Scans/2026/02/09/18/56/Noninvasive-Predictors</link>                    <description>In patients with severe mitral regurgitation (MR), low left atrial (LA) reservoir strain (LASr) and prior atrial fibrillation (AFib) intervention or LA appendage (LAA) ligation may predict low invasive LA compliance and limited V-wave reduction after transcatheter mitral valve therapy (TMVT)...</description>
                    <pubdate>1770667920000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Mechanisms Causing AV Block During TAVR Differ From Delayed Heart Block</title>
<link>/Latest-in-Cardiology/Journal-Scans/2025/12/17/15/00/Mechanisms-Causing-AV-Block</link>                    <description>Among patients undergoing TAVR, the characteristics and mechanisms causing atrioventricular (AV) conduction block during the procedure differed from those after the procedure, according to a study published Dec. 10 in JAMA Cardiology.</description>
                    <pubdate>1765996440000</pubdate>
                    <category>Articles and Stories</category>
                </item>
                <item>
                    <title>Eagle&#226;€™s Eye View: Highlights From 2025 TCT Conference </title>
<link>/Latest-in-Cardiology/Articles/2025/11/05/14/21/eagles-eye-view-05nov2025</link>                    <description>In this week&#226;€™s View, Dr. Eagle highlights several trials recently presented at the TCT Conference in San Francisco.</description>
                    <pubdate>1762352580000</pubdate>
                    <category>Articles and Stories</category>
                </item>

    </channel>
</rss>